Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2007

Conditions
Alzheimer's Disease
Interventions
DRUG

PRX-03140

Trial Locations (17)

19046

The Clinical Trial Center, LLC, Jenkintown

29615

Alliance for Neuro Research, LLC, Greenville

30308

Atlanta Center for Medical Research, Atlanta

33137

Miami Jewish Home and Hospital for the Aged, Miami

33317

Berma Research, Plantation

33702

Comprehensive NeuroScience, Inc, St. Petersburg

33709

Meridien Research, St. Petersburg

45408

Neurology Specialists, Dayton

71104

J. Gary Booker, MD, Shreveport

74104

Saint Johns Office Building, Tulsa

90505

Torrance Clinical Research, Torrance

90723

California Clinical Trials Medical Group, Inc, Paramount

92103

Pacific Research Network, Inc, San Diego

94109

Southwest CLinical Research, Rancho Mirage

San Francisco Clinical Research Center, San Francisco

06820

Research Center for Clinical Studies, Darien

01201

Neuroscience Research of the Berkshires, Pittsfield

Sponsors
All Listed Sponsors
lead

Epix Pharmaceuticals, Inc.

INDUSTRY